Prognostic factors for disease progression in advanced Hodgkin's disease: an analysis of patients aged under 60 years showing no progression in the first 6 months after starting primary chemotherapy.

The aim of this study was to determine whether a very high-risk group based on presenting characteristics could be identified in patients with advanced Hodgkin's disease who may benefit from high-dose chemotherapy (HDCT). Between 1975 and 1992, 453 previously untreated patients aged under 60 ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, S. M., Radford, J. A., Ryder, W. D., Collins, C. D., Deakin, D. P., Crowther, D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2222699/
https://www.ncbi.nlm.nih.gov/pubmed/9000607

Ejemplares similares

Ejemplares similares